Hamish Baillie Acquires 1,200 Shares of The Biotech Growth Trust PLC (LON:BIOG) Stock

The Biotech Growth Trust PLC (LON:BIOG - Get Free Report) insider Hamish Baillie bought 1,200 shares of the firm's stock in a transaction that occurred on Thursday, December 19th. The stock was bought at an average cost of GBX 856 ($10.70) per share, for a total transaction of £10,272 ($12,838.40).

Hamish Baillie also recently made the following trade(s):

• On Wednesday, November 27th, Hamish Baillie bought 3,000 shares of The Biotech Growth Trust stock. The shares were purchased at an average price of GBX 931 ($11.64) per share, for a total transaction of £27,930 ($34,908.14).

The Biotech Growth Trust Price Performance

Shares of BIOG traded up GBX 5 ($0.06) during mid-day trading on Friday, reaching GBX 868 ($10.85). The stock had a trading volume of 39,402 shares, compared to its average volume of 72,869. The company has a debt-to-equity ratio of 13.03, a quick ratio of 0.00 and a current ratio of 0.33. The Biotech Growth Trust PLC has a 12 month low of GBX 840.94 ($10.51) and a 12 month high of GBX 1,068.36 ($13.35). The business has a fifty day moving average of GBX 973.28 and a 200 day moving average of GBX 995.47. The firm has a market cap of £278.89 million, a price-to-earnings ratio of 419.32 and a beta of 0.50.

About The Biotech Growth Trust

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations.